The intensive care unit (ICU), at Red Deer Regional Hospital Centre (RDRHC) is participating in an international clinical trial aimed at treating kidney failure and reducing mortality.
The clinical trial – consisting of 34 patients – is led by Dr. Sean Bagshaw, chair of the Department of Critical Care Medicine at the University of Alberta and scientific director of AHS’ Critical Care Strategic Clinical Network.
The study is called Standard vs. Accelerated Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury trial (STARRT-AKI). It investigates whether an early start to renal replacement therapy (RRT), or dialysis, in critically ill patients is the best time to use the therapy.
RRT replaces the normal blood-filtering function of the kidneys and is used when a patient experiences renal failure due to acute kidney injury or chronic kidney disease.
The Red Deer team is led by Dr. Michael Russell and acute care manager Gillian Brown.
“Acute kidney injury is one of the things we struggle with and, if we can help turn that around earlier for patients, they’ll have better outcomes,” said Brown in a prepared statement. “That is the hope — our aim — to always look at the factors that put them at compromise and see how early we can turn that around.”
In total, 168 sites across 15 countries — including Canada, Australia, New Zealand, China, United Kingdom and France — participated and enrolled more than 3,000 patients.
Like and follow us on Facebook
Keep up with Alberta’s top stories Follow us on TwitterFollow @AlbertaPress